In addition, a study investigating the effects of FGF2 administration to Crouzon Syndrome (FGFr Autosomal Dominant Craniosynostosis Syndrome) patient derived parietal bone osteoblasts suggested an inverse relationship between FGF2 and DCN [40]. Here, FGF2 is linked to Crouzon disease.